Lupin Q1 Profit Jumps 43%, Margins Up

  Published 8 months ago

Lupin’s Q1 FY26 PBT rose 42.55% YoY with strong U.S. sales, margin expansion, and increased R&D investments.

  • U.S. sales surged 24.3% YoY to Rs 2,404.1 crore, making up 39% of global revenue in Q1 FY26.
  • EBITDA margin improved by 560 bps to 29.3%, driven by operational efficiency and strategic investments.
  • R&D spend rose 38.4% YoY to Rs 484.4 crore, supporting 2 new USFDA approvals and 342 cumulative clearances.

You might like these

Zomato Parent Boosts Nifty, Sensex

McDonald's Eyes India for AI Expansion

Angel One Sees Client Growth, Turnover Drop

India’s Electronics Export Boom

Tata Steel UK Begins Green Shift

RBI's New ECL Provisioning Framework

Denosumab Biosimilars Approved in Europe for Bone Conditions

News that matters the most ⚡